3-(4-甲氧基苯基)-5-异噁唑羧酸 | 618383-47-4

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 3-(4-甲氧基苯基)-5-异噁唑羧酸
• 中文别名: 3-(4-甲氧基苯基)-5-异恶唑甲酸；3-(4-甲氧基苯基)异恶唑-5-羧酸
• 英文名称: 3-(4-methoxyphenyl)-5-isoxazolylcarboxylic acid
• 英文别名: 3-(4-methoxyphenyl)isoxazole-5-carboxylic acid；3-(4-methoxyphenyl)-5-carboxyisoxazole；3-(4-methoxyphenyl)-5-isoxazolecarboxylic acid；3-(4-methoxyphenyl)-1,2-oxazole-5-carboxylic acid
• CAS: 618383-47-4
• 化学式: C₁₁H₉NO₄
• mdl: MFCD04124288
• 分子量: 219.197
• InChiKey: WEFMAZCRNQZFAY-UHFFFAOYSA-N

物化性质

• 熔点：
  223-225
• 沸点：
  461.1±40.0 °C(Predicted)
• 密度：
  1.310±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  72.6
• 氢给体数：
  1
• 氢受体数：
  5

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2934999090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-(4-Methoxyphenyl)-5-isoxazolecarboxylic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-(4-Methoxyphenyl)-5-isoxazolecarboxylic acid
CAS number: 618383-47-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H9NO4
Molecular weight: 219.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-(4-甲氧基苯基)-5-异噁唑羧酸 在 吡啶 、 4-二甲氨基吡啶 、 氯化亚砜 作用下， 反应 1.0h， 生成 C3′-N-[3-(4-methoxyphenyl) isoxazole-5-acyl]docetaxel
  参考文献：
  名称：

  具有C3'-N修饰的新型异恶唑-多西他赛类似物的合成，细胞毒活性和结合模型分析

  摘要：

  结构-活性关系（SAR）研究证实，C-3'位置的修饰可导致开发出高效的新型紫杉烷类。我们通过将异恶唑基引入C3'- N位，设计并合成了一系列新型的异恶唑-多西他赛类似物A1 - A5。与多西紫杉醇相比，所有合成的化合物对人癌细胞Hela，A2780，A549，MCF-7和SK-OV-3的细胞毒性活性均优于多西他赛。与多西他赛相比，这些化合物对耐药性癌细胞系A2780-MDR和MCF-7-MDR的抑制作用也更高。A1 – A5的绑定模型分析分子到微管（MT）的分子显示这些化合物被锚定在活性位点上，说明了它们在体外对MT的抑制作用。计算出的结合自由能值与A1 - A5化合物对癌细胞的IC 50值呈正相关。这些结果有力地证明了将异恶唑基引入C-3'位置确实改善了类紫杉醇的细胞毒活性的说法。

  DOI：

  10.1007/s00044-018-2151-7
• 作为产物：
  描述：

  对甲氧基苯甲醛肟 在 sodium hydroxide 、 chloroamine-T 、 铜 、 copper(II) sulfate 作用下， 以 水 、 叔丁醇 为溶剂， 生成 3-(4-甲氧基苯基)-5-异噁唑羧酸
  参考文献：
  名称：

  一锅铜（I）催化合成3,5-二取代异恶唑

  摘要：

  通过便利的一锅三步程序，利用原位生成的腈氧化物和末端乙炔之间的区域选择性铜（I）催化的环加成反应，以方便的一锅三步程序以高收率获得了3,5-二取代的异恶唑。大多数官能团不干扰反应，该反应可以在水性溶剂中进行而无需氧气的保护。由于所有试剂都以化学计量的形式使用，因此副产物的形成得以最小化。

  DOI：

  10.1021/jo050163b

文献信息

• [EN] CYCLIC AMINE SUBSTITUTED OXAZOLIDINONE CETP INHIBITOR<br/>[FR] INHIBITEUR DE CETP SUBSTITUÉ PAR DES AMINES CYCLIQUES À BASE D'OXAZOLIDINONE
  申请人：MERCK SHARP & DOHME

  公开号：WO2012058187A1

  公开（公告）日：2012-05-03

  CCompounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compound of Formula I, A3 is a substitiuted phenyl group or indanyl group.Formula (I).

  具有公式I结构的化合物，包括这些化合物的药用盐，是CETP抑制剂，可用于提高HDL胆固醇，降低LDL胆固醇，并用于治疗或预防动脉粥样硬化。在公式I的化合物中，A3是一个取代苯基或茚基。公式（I）。
• Concise Synthesis and Antimicrobial Activities of New Substituted 5-Isoxazolpenicillins
  作者：Xi-Zhao Wang、Jiong Jia、Yan Zhang、Wei-Ren Xu、Wei Liu、Fang-Niu Shi、Jian-Wu Wang

  DOI：10.1002/jccs.200700092

  日期：2007.6

  The synthesis of a series of new 5-isoxazolpenicillins is described, which were obtained by coupling substituted isoxazoles with 6-APA. Concise large-scale synthesis of 3,5-disubstituted isoxazoles by 1,3-dipolar cycloaddition using copper(I) as catalyst was also investigated. Representative compounds were assayed for antimicrobial activities, showing satisfactory antimicrobial activities against Gram-negative

  描述了一系列新的 5-异恶唑青霉素的合成，它们是通过将取代的异恶唑与 6-APA 偶联获得的。还研究了使用铜 (I) 作为催化剂通过 1,3-偶极环加成反应大规模合成 3,5-二取代异恶唑。对代表性化合物进行了抗微生物活性测定，显示出对革兰氏阴性菌令人满意的抗微生物活性。
• PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS
  申请人：Knust Henner

  公开号：US20100256126A1

  公开（公告）日：2010-10-07

  The present application relates to compounds of formula wherein the definitions are as described herein. The present compounds are high potential NK-3 receptor antagonists that are useful for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).

  本申请涉及以下式子的化合物，其中定义如本文所述。这些化合物是高潜力的NK-3受体拮抗剂，可用于治疗抑郁症、疼痛、精神病、帕金森病、精神分裂症、焦虑症和注意力缺陷多动障碍（ADHD）。
• Cyclic Amine Substituted Oxazolidinone CETP Inhibitor
  申请人：Lu Zhijian

  公开号：US20130331372A1

  公开（公告）日：2013-12-12

  Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compound of Formula I, A 3 is a substituted phenyl group or indanyl group. Formula (I).

  具有I式结构的化合物，包括化合物的药学上可接受的盐，是CETP抑制剂，可用于提高HDL胆固醇，降低LDL胆固醇，并用于治疗或预防动脉粥样硬化。在I式化合物中，A3是取代苯基或茚环基。I式如下：
• Cyclic amine substituted oxazolidinone CETP inhibitor
  申请人：Lu Zhijian

  公开号：US09221834B2

  公开（公告）日：2015-12-29

  Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compound of Formula I, A3 is a substituted phenyl group or indanyl group. Formula (I).

  具有公式I结构的化合物，包括该化合物的药学上可接受的盐，是CETP抑制剂，可用于提高HDL胆固醇，降低LDL胆固醇，并用于治疗或预防动脉粥样硬化。在公式I的化合物中，A3是取代苯基或吲哚基。公式（I）。